A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...

A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side ...

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...

ABC News' Dr. Tara Narula explains a new study indicating that stopping GLP 1 weight loss medications too soon could make it harder to lose weight.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.